MERCK Kommanditgesellschaft auf Aktien (MRK.DE)
EUR 124.6
(2.21%)
EUR 124.6
(2.21%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2023 | 20.99 Billion EUR | -5.57% |
| 2022 | 22.23 Billion EUR | 12.93% |
| 2021 | 19.68 Billion EUR | 12.28% |
| 2020 | 17.53 Billion EUR | 8.56% |
| 2019 | 16.15 Billion EUR | 8.87% |
| 2018 | 14.83 Billion EUR | -3.2% |
| 2017 | 15.32 Billion EUR | 2.02% |
| 2016 | 15.02 Billion EUR | 16.97% |
| 2015 | 12.84 Billion EUR | 11.69% |
| 2014 | 11.5 Billion EUR | 3.66% |
| 2013 | 11.09 Billion EUR | -0.7% |
| 2012 | 11.17 Billion EUR | 8.72% |
| 2011 | 10.27 Billion EUR | 10.61% |
| 2010 | 9.29 Billion EUR | 19.93% |
| 2009 | 7.74 Billion EUR | 2.5% |
| 2008 | 7.55 Billion EUR | 7.1% |
| 2007 | 7.05 Billion EUR | 12.76% |
| 2006 | 6.25 Billion EUR | 6.61% |
| 2005 | 5.87 Billion EUR | 9.94% |
| 2004 | 5.33 Billion EUR | -25.86% |
| 2003 | 7.2 Billion EUR | -2.67% |
| 2002 | 7.39 Billion EUR | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 5.35 Billion EUR | 4.53% |
| 2024 Q1 | 5.12 Billion EUR | -2.01% |
| 2023 Q1 | 5.29 Billion EUR | -6.48% |
| 2023 Q2 | 5.3 Billion EUR | 0.17% |
| 2023 FY | 20.99 Billion EUR | -5.57% |
| 2023 Q4 | 5.22 Billion EUR | 1.01% |
| 2023 Q3 | 5.17 Billion EUR | -2.43% |
| 2022 FY | 22.23 Billion EUR | 12.93% |
| 2022 Q1 | 5.19 Billion EUR | -0.29% |
| 2022 Q2 | 5.56 Billion EUR | 7.12% |
| 2022 Q4 | 5.66 Billion EUR | -2.51% |
| 2022 Q3 | 5.8 Billion EUR | 4.27% |
| 2021 Q3 | 4.97 Billion EUR | 2.11% |
| 2021 Q4 | 5.21 Billion EUR | 4.83% |
| 2021 FY | 19.68 Billion EUR | 12.28% |
| 2021 Q1 | 4.63 Billion EUR | 0.72% |
| 2021 Q2 | 4.87 Billion EUR | 5.16% |
| 2020 FY | 17.53 Billion EUR | 8.56% |
| 2020 Q1 | 4.37 Billion EUR | -0.25% |
| 2020 Q2 | 4.11 Billion EUR | -5.74% |
| 2020 Q3 | 4.44 Billion EUR | 7.96% |
| 2020 Q4 | 4.59 Billion EUR | 3.4% |
| 2019 Q4 | 4.38 Billion EUR | 8.07% |
| 2019 Q1 | 3.74 Billion EUR | -3.63% |
| 2019 Q2 | 3.97 Billion EUR | 6.01% |
| 2019 Q3 | 4.05 Billion EUR | 2.09% |
| 2019 FY | 16.15 Billion EUR | 8.87% |
| 2018 Q4 | 3.88 Billion EUR | 3.68% |
| 2018 Q2 | 3.71 Billion EUR | 0.62% |
| 2018 Q1 | 3.69 Billion EUR | -4.08% |
| 2018 FY | 14.83 Billion EUR | -3.2% |
| 2018 Q3 | 3.74 Billion EUR | 0.94% |
| 2017 Q3 | 3.72 Billion EUR | -4.21% |
| 2017 Q2 | 3.89 Billion EUR | 0.78% |
| 2017 Q1 | 3.86 Billion EUR | 0.81% |
| 2017 FY | 15.32 Billion EUR | 2.02% |
| 2017 Q4 | 3.84 Billion EUR | 3.25% |
| 2016 Q1 | 3.66 Billion EUR | 5.81% |
| 2016 Q4 | 3.83 Billion EUR | 2.85% |
| 2016 Q3 | 3.72 Billion EUR | -2.13% |
| 2016 Q2 | 3.8 Billion EUR | 3.82% |
| 2016 FY | 15.02 Billion EUR | 16.97% |
| 2015 Q2 | 3.21 Billion EUR | 5.86% |
| 2015 FY | 12.84 Billion EUR | 11.69% |
| 2015 Q4 | 3.46 Billion EUR | 11.0% |
| 2015 Q3 | 3.12 Billion EUR | -3.08% |
| 2015 Q1 | 3.04 Billion EUR | 0.16% |
| 2014 Q4 | 3.03 Billion EUR | 3.41% |
| 2014 FY | 11.5 Billion EUR | 3.66% |
| 2014 Q1 | 2.66 Billion EUR | -2.8% |
| 2014 Q2 | 2.86 Billion EUR | 7.44% |
| 2014 Q3 | 2.93 Billion EUR | 2.56% |
| 2013 Q2 | 2.84 Billion EUR | 2.92% |
| 2013 FY | 11.09 Billion EUR | -0.7% |
| 2013 Q4 | 2.74 Billion EUR | -0.37% |
| 2013 Q3 | 2.75 Billion EUR | -3.14% |
| 2013 Q1 | 2.76 Billion EUR | -2.62% |
| 2012 FY | 11.17 Billion EUR | 8.72% |
| 2012 Q1 | 2.64 Billion EUR | 0.74% |
| 2012 Q2 | 2.85 Billion EUR | 7.83% |
| 2012 Q4 | 2.83 Billion EUR | -0.22% |
| 2012 Q3 | 2.84 Billion EUR | -0.39% |
| 2011 Q2 | 2.55 Billion EUR | -0.33% |
| 2011 Q3 | 2.53 Billion EUR | -0.93% |
| 2011 Q4 | 2.62 Billion EUR | 3.72% |
| 2011 FY | 10.27 Billion EUR | 10.61% |
| 2011 Q1 | 2.56 Billion EUR | 0.7% |
| 2010 Q4 | 2.54 Billion EUR | 4.43% |
| 2010 FY | 9.29 Billion EUR | 19.93% |
| 2010 Q3 | 2.43 Billion EUR | 10.41% |
| 2010 Q1 | 2.09 Billion EUR | 3.46% |
| 2010 Q2 | 2.2 Billion EUR | 5.2% |
| 2009 Q1 | 1.85 Billion EUR | 0.0% |
| 2009 Q2 | 1.9 Billion EUR | 2.75% |
| 2009 FY | 7.74 Billion EUR | 2.5% |
| 2009 Q3 | 1.95 Billion EUR | 2.11% |
| 2009 Q4 | 2.02 Billion EUR | 4.04% |
| 2008 FY | 7.55 Billion EUR | 7.1% |
| 2007 FY | 7.05 Billion EUR | 12.76% |
| 2006 FY | 6.25 Billion EUR | 6.61% |
| 2005 FY | 5.87 Billion EUR | 9.94% |
| 2004 FY | 5.33 Billion EUR | -25.86% |
| 2003 FY | 7.2 Billion EUR | -2.67% |
| 2002 FY | 7.39 Billion EUR | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| MPH Health Care AG | 34.43 Million EUR | -60872.107% |
| Apontis Pharma AG | 36.96 Million EUR | -56693.411% |
| Dermapharm Holding SE | 1.13 Billion EUR | -1749.032% |
| Evotec SE | 781.42 Million EUR | -2586.499% |
| PharmaSGP Holding SE | 101.09 Million EUR | -20664.795% |
| SynBiotic SE | 3.86 Million EUR | -543569.115% |